Plasmid-based genes offer promise for a new generation of vaccines and for
gene therapy, but the size and character of plasmids pose new challenges to
biochemical engineers. By acknowledging these and using bioprocess-design
information based on fundamental studies of the system's properties, it wil
l be possible to create efficient and consistent processes for these materi
als. This review addresses the purity required, the key issue of the sensit
ivity of the chromosomal DNA contaminant and larger plasmids to hydrodynami
c forces, and the impact of this and other characteristics of plasmids on t
he recovery and purification of DNA for pharmaceutical purposes.